Heart Test Laboratories Inc (NASDAQ: HSCS) stock fell -1.60% on Friday to $0.17 against a previous-day closing price of $0.17. With 8.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.18 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.1711 whereas the lowest price it dropped to was $0.1549. The 52-week range on HSCS shows that it touched its highest point at $3.95 and its lowest point at $0.14 during that stretch. It currently has a 1-year price target of $3.80. Beta for the stock currently stands at 3.67.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HSCS was up-trending over the past week, with a rise of 5.14%, but this was down by -56.39% over a month. Three-month performance dropped to -76.66% while six-month performance fell -80.95%. The stock lost -90.53% in the past year, while it has lost -80.27% so far this year. A look at the trailing 12-month EPS for HSCS yields -0.67 with Next year EPS estimates of -0.56. For the next quarter, that number is -0.12. This implies an EPS growth rate of 36.25% for this year and -9.80% for next year.
Float and Shares Shorts:
At present, 10.12 million HSCS shares are outstanding with a float of 7.44 million shares on hand for trading. On Oct 30, 2023, short shares totaled 47120.0, which was 0.43% higher than short shares on Sep 28, 2023. In addition to Mr. Andrew Simpson as the firm’s CEO, President & Chairman of the Board of Directors, Ms. Danielle Watson serves as its CFO & Treasurer.
Institutional Ownership:
Through their ownership of 5.30% of HSCS’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HSCS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HSCS analysts setting a high price target of $3.80 and a low target of $3.80, the average target price over the next 12 months is $3.80. Based on these targets, HSCS could surge 2135.29% to reach the target high and rise by 2135.29% to reach the target low. Reaching the average price target will result in a growth of 2135.29% from current levels.
